In addition, vaccination aimed at existed tumor mutations or cytokine therapy are often faced with resistance through up-regulation of immune inhibitory checkpoint molecules including PD-1/PD-L1 pathway (111, 119). This evidence concerns the gene CD274 and neoplasm.